EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/1063625
EW CATARACT 26 January 2019 Device focus by Michelle Stephenson EyeWorld Contributing Writer and the capsule lasered, patient satisfaction at a month is quite high but even higher at a year," Dr. Thompson said. "I tell patients that we're embarking on a year-and- a-half journey together and that they'll most likely experience some impressive improvements along the way, but at the end of that year and a half, they'll have some of the world's most advanced optics in their eyes to help them do a lot without glasses at multiple distances for the rest of their life. The patients that go into it with this attitude do beautifully." Dr. Berdahl agreed. "I think we're seeing the continued improve- ment of presbyopia-correcting IOLs in an iterative fashion because of all the experience that we've had with them, and it's great to be part of an innovative profession that's getting better every day," he said. The future Dr. Neuhann said he doesn't see a future for bifocals. "When a multifo- cal is the option, use a trifocal. I do not see a place for bifocals anymore. Trifocals offer everything a bifocal can plus the intermediate vision at no extra expense. Realize—and make patients realize—that with presbyopia, everything is a compro- mise. We have the privilege to have multiple compromises available, with different advantage/disadvan- tage profiles, to choose from. But we must never forget that they are all compromises. We do not have the option that everyone wants, namely, 'back to youth' vision with accommodation," he said. EW Editors' note: Dr. Berdahl has finan- cial interests with Alcon, Johnson & Johnson Vision (Santa Ana, Califor- nia), RxSight (Aliso Viejo, California), and Bausch + Lomb (Bridgewater, New Jersey). Dr. Thompson has financial in- terests with Alcon, Johnson & Johnson, and Carl Zeiss Meditec. Dr. Neuhann has no financial interests related to his comments. Contact information Berdahl: john.berdahl@vancethompsonvision.com Neuhann: prof@neuhann.de Thompson: vance.thompson@vancethompsonvision.com the patient has a healthy macula, and that's why doing an OCT is so important. Of course, we also need to be able to enhance the patient's cornea with PRK or LASIK to op- timize the optics to plano. That is why a corneal refractive workup needs to be a part of any premium implant evaluation. We don't want to have a patient with residual refractive error postoperatively who we can't enhance with the laser because they have a topographic ir- regularity or other contraindication to a laser fine tune. We want to find these issues preoperatively and do a monofocal IOL in these situations. But as long as the tear film, cornea, and macula are healthy and the pos- terior capsule is clear after implant surgery, whether it took a capsu- lotomy or not, and the refractive error is near plano with or without an enhancement, this adds up to extremely high patient satisfaction," Dr. Thompson said. Dr. Neuhann agreed. "I would not use them in patients with addi- tional contrast lowering and/or light dispersion conditions, such as cor- neal guttata, pronounced dry eye, prior corneal laser vision correction with imperfect contrast sensitivity, and/or light phenomena," he said. He advised extreme caution with prior low myopes. "Their lifelong excellent uncorrected near vision and, consequently, expecta- tion is a great danger for disappoint- ment with the near vision with such lenses," he said. Pearls Dr. Thompson explains to patients that achieving the desired outcome is a four-step process. First is the implantation of the advanced trifocal, bifocal, or extend- ed depth of focus implant. Second, 3 months later, if there's any residual refractive error, an enhancement is performed using PRK or LASIK. Third, if the posterior cap- sule develops opacity a YAG laser is performed. More YAGs will be performed because a subtle posteri- or capsule opacity can degrade the optics of the implant more quickly than a monofocal implant. Fourth is neural-adaptation. "After the implant is in, the refrac- tive error minimized with a fine tune or the patient ended up plano, that they provide vision at all three distances. "No currently avail- able single lens provides distance, intermediate, and near vision," Dr. Berdahl said. "Trifocals would give each eye the ability to see well at all three distances, which I suspect will allow for more forgiveness if we aren't exactly on target." "Because all multifocal IOLs divide the incoming light into more than one focus, the effect of the light in 'out of focus' images reduces the contrast of 'in focus' images," Dr. Thompson said. "If a patient is looking at a distance, he or she will have near and intermediate images that are not in focus, which can reduce contrast sensitivity and modulation transfer function (MTF). MTF is a useful optics measure of true or effective resolution, since it accounts for the amount of blur and contrast over a range of spatial frequencies. As a result, unwanted visual phenomena, including glare and halo, can occur. One of the main reasons that multifocal IOLs are being implanted with growing frequency is because the optics have been optimized to the point that patient satisfaction is much higher than multifocal implants of 10 or 20 years ago. There is a much lower incidence of glare and halos. Twenty years ago, they were 0.1% of the implants I placed, and now multi- focals are 40% of the implants that I use because of how happy they make my patients who desire to be spectacle independent. I have been in trifocal FDA trials in the United States, and I think they're going to be a game-changer for us, too." However, there are certain patients for whom Dr. Thompson would be cautious about recom- mending any implant that splits light, whether it is an EDOF or mul- tifocal lens. Any eye pathology that scatters light in an unsophisticated way can degrade the sophisticated optics of modern-day multifocals or EDOF lenses. "For example, dry eye, epithelial basement membrane dystrophy, or a corneal irregulari- ty, such as keratoconus, should be treated before implantation of a trifocal. If we cannot decrease the higher order aberration state of the cornea and tear film to an accept- able level, we don't want to add a multifocal implant to that optical system. We also like to make sure Although not yet approved for use in the United States, trifocal IOLs are providing near, intermediate, and distance vision to patients in Europe and Canada B ecause multifocal IOLs do not provide optimal inter- mediate vision, surgeons often mix and match IOLs to achieve the best vision at all three distances. "We will either implant an extended depth of focus (EDOF) IOL or a lower add multifocal in the dominant eye, and we will implant a higher add bifocal in the non-dominant eye in an attempt to get all three distances," said Vance Thompson, MD, Sioux Falls, South Dakota. In contrast, trifocals can be implanted in both eyes because they provide vision at all three distances. Three trifocal IOLs are currently approved for use outside of the United States: the AT LISA (Carl Zeiss Meditec, Jena, Germany), the AcrySof IQ PanOptix (Alcon, Fort Worth, Texas), and the FineVision (PhysIOL, Liège, Belgium). According to Thomas Neu- hann, MD, Munich, Germany, the basic principle of two diffractive step-widths combined to provide distance, intermediate, and near foci is used by all of these lenses. "The Alcon lens uses a particular diffractive construction to obtain an intermediate range from 1.2 to 0.6 m. The intermediate focus is not created at the expense of the light distributed to the distance and near foci but makes light otherwise lost, such as in bifocal diffractive lenses, available and usable for the interme- diate focus," he explained. John Berdahl, MD, Sioux Falls, South Dakota, noted that the adoption rate of trifocals outside of the United States has been tremen- dous. "In many places, it's the go-to lens type. It is about defocus curves and trying to provide as much of a continuous range of vision as possi- ble, while avoiding unwanted side effects like positive dysphotopsias," he said. Advantages and disadvantages The advantage of trifocal IOLs is Trifocal IOLs provide near, intermediate, and distance vision